Called $CRDO bullish on Sep 4, 2025: $CRDO rose 24% in 8 weeks.
View call →
Growth Stock Forum founder. Seeking Alpha author. Investor. Trader.
Cite asCryptoQuant has tracked the directional calls on ARWR by @ONeilTrader on X since Jun 2019: not yet scored on ARWR (as of Nov 11, 2026).
4 ARWR calls on record, a thin history.
Relative view by default: fewer than 30 ARWR calls or days on record.
Sentiment timeline shows relative sentiment within this analyst's history. A perma-bull showing 8 bullish : 2 bearish in a bear market sets that as their baseline. If you notice any errors, claim @ONeilTrader to submit corrections.
Called $CRDO bullish on Sep 4, 2025: $CRDO rose 24% in 8 weeks.
View call →Hover the chart to read the thesis of that period · click a day to pin it
$NVS - Leqvio net sales +63% Y/Y to $508 million. - Updated FDA label for Leqvio includes language recognizing that lowering LDL-C reduces the risk of major adverse cardiovascular events based on established evidence from statins and PCSK9 inhibitors, supporting LDL-C reduction as a key component of cardiovascular risk management. - ORION-4 outcomes trial (secondary prevention) topline results this quarter. Potential positive labeling read-through to $ARWR ARO-DIMER-PA (lowers PCSK9 like Leqvio but also APOC3).
View original →$ARWR update published @SeekingAlpha on ARO-MAPT https://t.co/zzaMFXNI8P With diranersen comps and associated cross-trial differences and caveats $BIIB $IONS And general directional thoughts toward the end, including latest pipeline progress (dimer platform validation) and STAR program grant from FDA on Redemplo.
View original →Very nice to see former $ALNY CEO offer compliments to $ARWR That's the true spirit of biotech. Go science https://t.co/EaRseVmGR8
View original →$ARWR ARO-MAPT results I had 50-60% CSF total tau reductions as base case, 70%+ as bull case in my preview to subs. Looks good at first glance. https://t.co/WV5360ch2f
View original →$ARWR Granted Entry in the FDA STAR Pilot Program for Plozasiran in Severe Hypertriglyceridemia Maybe they can now sell the PRV voucher they bought for $215m https://t.co/31e4HnaSAI
View original →
